Safety of intravenous ivabradine in acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention: A randomized, placebo-controlled, double-blind, pilot study

European Heart Journal: Acute Cardiovascular Care

Volumn 2, Issue 3, 2013, Pages 270-279

  Steg, P G ^a,b,c   Lopez de Sa E ^d   Schiele, F ^e   Hamon, M ^c,f   Meinertz, T ^g   Goicolea, J ^h   Werdan, K ⁱ   Lopez Sendon, J L ^d  

^a BICHAT HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^f CHU CÔTE DE NACRE   (France)

^g UNIVERSITY HEART CENTER HAMBURG   (Germany)

^h HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

ⁱ MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROMES (ACS); HEART RATE; IVABRADINE; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; BENZAZEPINES; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PILOT PROJECTS; TACHYCARDIA; TREATMENT OUTCOME;

EID: 84898444906     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872613489305     Document Type: Article

References (16)